The final word! MGI made DNBSEQ-E5 to help Hunan Yiyang CDC complete the traceability of the new coronavirus for the first time

On July 14, 2022, in Ziyang District, Yiyang City, Hunan Province, during the routine nucleic acid test of the quarantined personnel at the centralized isolation medical observation point, it was found that one case of the returnee from the epidemic-related area outside the province was initially screened positive for the nucleic acid test

At noon on July 15, the Municipal Party Committee and Municipal Government issued an invitation to MGI to conduct traceability analysis of COVID-19 on positive nucleic acid test samples

The gene sequencing equipment was delivered to the Municipal Center for Disease Control and Prevention on the night of July 15th.

Previously, the National Development and Reform Commission and other four departments jointly issued the "14th Five-Year Plan" Implementation Plan for the Construction of High-Quality and Efficient Medical and Health Service System, which pointed out that the national and key regional disease prevention and control institutions must have new infectious disease pathogens and health hazards.

With the support of MGI's gene sequencing equipment, the Yiyang CDC has completed the traceability analysis of the new crown quickly and accurately, which indicates that the Yiyang CDC has initially possessed the ability to sequence the genes of the new coronavirus, which is helpful for Yiyang's new crown pneumonia epidemic and the epidemic.

MGI has created a portfolio of novel coronavirus targeted sequencing products based on DNBSEQ technology, which has helped nearly 100 disease control centers in more than ten provinces across the country to trace the source of the new coronavirus, providing an effective basis for epidemic prevention and control, and comprehensively assisting the identification and traceability of the new coronavirus in various places.

At present, SE100 sequencing based on the new optimized and accelerated DNBSEQ-E5 and its rapid sequencing reagents can complete the entire process from DNB loading to FASTQ file output within 3.

As the creator of core tools of life science and technology, MGI has always been well aware of the expectation of shortening the sample turnaround time in various application fields such as public health and precision medicine